NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer immunotherapy strategies for more patients

By Newsroom America Feeds at 12 Oct 10:31

Having trouble viewing this email? View it as a Web page https://content.govdelivery.com/accounts/USNIH/bulletins/1bd06d3.

Bookmark and Share https://content.govdelivery.com/accounts/USNIH/bulletins/1bd06d3?reqfrom=share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer immunotherapy strategies for more patients https://www.nih.gov/news-events/news-releases/nih-partners-11-leading-biopharmaceutical-companies-accelerate-development-new-cancer-immunotherapy-strategies-more-patients 10/12/2017 10:00 AM EDT Supports Cancer Moonshot goal to bring immunotherapy success to more patients in half the time. ________________________________________________________________________

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL